Evidence map›Paper›PMID 22570617›Full record

SynthesisPLoS genetics2012

Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.

Janey L Wiggs, Brian L Yaspan, Michael A Hauser, Jae H Kang, R Rand Allingham, Lana M Olson, Wael Abdrabou, Bao J Fan, Dan Y Wang, Wendy Brodeur and 40 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 15 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 15 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Review
  19. Variant-to-gene mapping identifiesbioRxiv : the preprint server for biology · 2026
    Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 1 country.

Janey L WiggsDepartment of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States of America. janey_wiggs@meei.harvard.edu
Brian L Yaspan
Michael A Hauser
Jae H Kang
R Rand Allingham
Lana M Olson
Wael Abdrabou
Bao J Fan
Dan Y Wang
Wendy Brodeur
Donald L Budenz
Joseph Caprioli
Andrew Crenshaw
Kristy Crooks
Elizabeth Delbono
Kimberly F Doheny
David S Friedman
Douglas Gaasterland
Terry Gaasterland
Cathy Laurie
Richard K Lee
Paul R Lichter
Stephanie Loomis
Yutao Liu
Felipe A Medeiros
Cathy McCarty
Daniel Mirel
Sayoko E Moroi
David C Musch
Anthony Realini
Frank W Rozsa
Joel S Schuman
Kathleen Scott
Kuldev Singh
Joshua D Stein
Edward H Trager
Paul Vanveldhuisen
Douglas Vollrath
Gadi Wollstein
Sachiko Yoneyama
Kang Zhang
Robert N Weinreb
Jason Ernst
Manolis Kellis
Tomohiro Masuda
Don Zack
Julia E Richards
Margaret Pericak-Vance
Louis R Pasquale
Jonathan L Haines
Duke University · USJohns Hopkins University · USMassachusetts Eye and Ear Infirmary · USUniversity of California, San Diego · USUniversity of Michigan–Ann Arbor · USHarvard University Press · USMassachusetts Institute of Technology · USMichigan United · USAnn Arbor Center for Independent Living · USBroad Institute · USUniversity of Miami · USUniversity of Pittsburgh · USVanderbilt University · USBrigham and Women's Hospital · USCenter for Human Genetics · USEmmes (United States) · USEssentia Health · USPalo Alto University · USSeattle University · USStanford University · US

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI RIMM, ERIC B · 1991 to 2009
$41.8M
A Center for GEI Association StudiesU01HG004424 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2007 to 2010
$21.4M
VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
Structural dynamics of developing auditory circuitsP20RR015574 · NCRR · WEST VIRGINIA UNIVERSITY · PI SPIROU, GEORGE A · 2000 to 2009
$18.1M
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1R01EY013178 · NEI · WILLS EYE HEALTH SYSTEM · PI Joel S Schuman · 2000 to 2026
$17.5M
SNP discoveryP01HL073042 · NHLBI · DUKE UNIVERSITY · PI NEVINS, JOSEPH R · 2002 to 2006
$13.5M
Unifying Genetics Epidemiology of Macular DegenerationR01EY012118 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AGARWAL, ANITA, HAINES, JONATHAN L · 2006 to 2015
$12.2M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
Diagnostic Innovations in Glaucoma:Structural AssessmentR01EY011008 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 1995 to 2015
$8.7M
Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
High-throughput sequencing of chromatin regulatory elementsU54HG004570 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BERNSTEIN, BRADLEY EVAN · 2007 to 2011
$8.1M
NCI NIH HHS CA49449NCI NIH HHS CA55075NCI NIH HHS CA87969NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS R01 CA049449NCI NIH HHS U01 CA049449NCRR NIH HHS P20 RR015574NCRR NIH HHS RR015574NEI NIH HHS 3R01EY015872-05S1NEI NIH HHS 3R01EY019126-02S1NEI NIH HHS EY006827NEI NIH HHS EY008208NEI NIH HHS EY009149NEI NIH HHS EY009847NEI NIH HHS EY010886NEI NIH HHS EY011008NEI NIH HHS EY011671NEI NIH HHS EY012118NEI NIH HHS EY013178NEI NIH HHS EY015473NEI NIH HHS EY015543NEI NIH HHS EY015682NEI NIH HHS EY015872NEI NIH HHS EY09580NEI NIH HHS EY13315NEI NIH HHS EY144428NEI NIH HHS EY144448NEI NIH HHS EY18660NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY008208NEI NIH HHS R01 EY009580NEI NIH HHS R01 EY009847NEI NIH HHS R01 EY010886NEI NIH HHS R01 EY011008NEI NIH HHS R01 EY011405NEI NIH HHS R01 EY011671NEI NIH HHS R01 EY012118NEI NIH HHS R01 EY013178NEI NIH HHS R01 EY013315NEI NIH HHS R01 EY015473NEI NIH HHS R01 EY015543NEI NIH HHS R01 EY015872NEI NIH HHS R01 EY018660NEI NIH HHS R01 EY019126NEI NIH HHS R01 EY020928NEI NIH HHS R01 EY021818NEI NIH HHS R01 EY022305NEI NIH HHS R01 EY022306NEI NIH HHS R03 EY015682NEI NIH HHS R56 EY011671NEI NIH HHS T32 EY021453NEI NIH HHS T32EY021453NEI NIH HHS U10 EY012118NHGRI NIH HHS HG004608NHGRI NIH HHS HG004728NHGRI NIH HHS HG005259-01NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS R01 HG004037NHGRI NIH HHS RC1 HG005334NHGRI NIH HHS RC1HG005334NHGRI NIH HHS U01 HG004424NHGRI NIH HHS U01-HG004424NHGRI NIH HHS U01 HG004446NHGRI NIH HHS U01 HG004608NHGRI NIH HHS U01 HG004728NHGRI NIH HHS U54 HG004570NHGRI NIH HHS U54HG004570NHLBI NIH HHS HL073389NHLBI NIH HHS HL73042NHLBI NIH HHS P01 HL073042NHLBI NIH HHS R01 HL073389
6 · The paper itself

Abstract

Optic nerve degeneration caused by glaucoma is a leading cause of blindness worldwide. Patients affected by the normal-pressure form of glaucoma are more likely to harbor risk alleles for glaucoma-related optic nerve disease. We have performed a meta-analysis of two independent genome-wide association studies for primary open angle glaucoma (POAG) followed by a normal-pressure glaucoma (NPG, defined by intraocular pressure (IOP) less than 22 mmHg) subgroup analysis. The single-nucleotide polymorphisms that showed the most significant associations were tested for association with a second form of glaucoma, exfoliation-syndrome glaucoma. The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63-0.75], p = 1.86×10⁻¹⁸), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21-1.43], p = 3.87×10⁻¹¹). In sub-group analysis two loci were significantly associated with NPG: 9p21 containing the CDKN2BAS gene (rs2157719 [G], OR = 0.58 [95% CI 0.50-0.67], p = 1.17×10⁻¹²) and a probable regulatory region on 8q22 (rs284489 [G], OR = 0.62 [95% CI 0.53-0.72], p = 8.88×10⁻¹⁰). Both NPG loci were also nominally associated with a second type of glaucoma, exfoliation syndrome glaucoma (rs2157719 [G], OR = 0.59 [95% CI 0.41-0.87], p = 0.004 and rs284489 [G], OR = 0.76 [95% CI 0.54-1.06], p = 0.021), suggesting that these loci might contribute more generally to optic nerve degeneration in glaucoma. Because both loci influence transforming growth factor beta (TGF-beta) signaling, we performed a genomic pathway analysis that showed an association between the TGF-beta pathway and NPG (permuted p = 0.009). These results suggest that neuro-protective therapies targeting TGF-beta signaling could be effective for multiple forms of glaucoma.

Indexed as

Genome-Wide Association StudyNerve DegenerationTransforming Growth Factor betaAllelesChromosomes, Human, Pair 8Chromosomes, Human, Pair 9Exfoliation SyndromeGlaucoma, Open-AngleHomeodomain ProteinsHumansOptic NervePolymorphism, Single NucleotideRNA, Long NoncodingRNA, UntranslatedCDKN2B antisense RNA, humanHomeodomain ProteinsRNA, Long NoncodingRNA, UntranslatedSIX1 protein, humanTransforming Growth Factor beta

Identifiers

PMID22570617
PMCPMC3343074
OpenAlexW1520863883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.